Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis.
Eicosapentaenoic acid (EPA) induces peroxisome proliferator-activated receptors and ameliorates experimental autoimmune encephalomyelitis.
The ketogenic diet as a treatment paradigm for diverse neurological disorders.
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.
Chronic inflammatory demyelinating polyneuropathy following malignant melanoma.
High-field imaging of neurodegenerative diseases.
Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response.
UVB light attenuates the systemic immune response in CNS autoimmunity.
Receptos provides update on progress of lead product candidate RPC1063
Effects of dalfampridine on multi-dimensional aspects of gait and dexterity in multiple sclerosis among timed walk responders and non-responders.
Mechanism for p38α-mediated experimental autoimmune encephalomyelitis.
Long-term effects of dalfampridine in patients with multiple sclerosis.
Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality.
The investigation of acute optic neuritis: a review and proposed protocol.
Tysabri prescribing information
Rituximab induces clonal expansion of IgG memory B-cells in patients with inflammatory central nervous system demyelination.
Lodonal/LDN
Unprovoked seizures in multiple sclerosis and systemic lupus erythematosus: A population-based case-control study.
Long term follow up of peripheral lymphocyte subsets in a cohort of multiple sclerosis patients treated with natalizumab.
Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis.
Magnetic resonance imaging in multiple sclerosis - patients' experiences, information interests and responses to an education programme.
Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis.
A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone
The cost burden of multiple sclerosis in the United States: a systematic review of the literature.
Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial.
Pages
« first
‹ previous
…
109
110
111
112
113
114
115
116
117
…
next ›
last »